1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The liraglutide injection therapeutics market is undergoing accelerated transformation driven by evolving reimbursement models, technological advances, and the rising need for integrated solutions targeting metabolic disease. Senior decision-makers are navigating complex, dynamic forces as they consider investments, portfolio growth, and operational strategies within this space.
Market Snapshot: Liraglutide Injection Market and Growth Trajectory
The global liraglutide injection market continues to expand at a strong pace, underpinned by robust demand for innovative GLP-1 agonists in obesity and type 2 diabetes management. Key milestones include expanded regulatory approvals, drug-device innovations facilitating ease of use, and increased adoption across diverse healthcare settings. The market’s growth potential is shaped by payers’ recognition of value-based contracts and the ongoing shift toward comprehensive chronic disease care solutions.
Scope & Segmentation of Liraglutide Injection Therapeutics
- Indications: Obesity (Class I, II, III), type 2 diabetes (adults, pediatrics).
- Distribution Channels: Hospital pharmacies (private, public), online pharmacies (manufacturer portals, third-party platforms), retail pharmacies (chain, independent).
- End Users: General and specialty clinics, home care (nurse-administered, self-administered), hospitals (private, public).
- Dosage Strengths: 0.6 mg, 1.2 mg, 1.8 mg formulations supporting flexible titration.
- Packaging Types: Pre-filled pens for patient convenience, single-dose vials for clinical adaptability.
- Major Regions: Americas (including United States, Canada, Latin America), Europe, Middle East & Africa, Asia-Pacific.
- Key Technology Drivers: Connected injection pens with digital dose tracking, integration with telemedicine, and patient engagement tools.
Primary Keyword in Focus: Liraglutide Injection Market
Key Takeaways for Senior Decision-Makers
- Stakeholder strategies are aligning to expand access and foster collaborative approaches supporting patient adherence and value-based care.
- Real-world studies affirm sustained market momentum, with consistent evidence supporting both efficacy and favorable tolerability profiles.
- Expanded use in both adult and pediatric segments is enhancing the therapy’s reach, while segmentation by obesity class addresses diverse clinical needs.
- Technological innovations, including connected delivery devices and telemedicine integration, reinforce patient support and optimize outcomes.
- Emerging biosimilars and alternative administration routes are intensifying competitive dynamics, motivating incumbent leaders to invest in lifecycle and partnership strategies.
- Regional access remains differentiated as market entry, distribution, and pricing models evolve to fit local regulatory and healthcare structures.
Tariff Impact and Operational Readiness
Imminent U.S. tariff adjustments set for 2025 could reshape input costs for overseas-sourced active pharmaceutical ingredients used in liraglutide injection manufacturing. Stakeholders are proactively evaluating sourcing diversification, onshore production capabilities, and strategic inventory buffers to mitigate supply chain risks. Payers may seek to update reimbursement benchmarks in response, with manufacturers justifying pricing strategies through outcomes-based and value-driven evidence.
Methodology & Data Sources
This analysis incorporates comprehensive secondary research from peer-reviewed journals, regulatory dossiers, and clinical trial databases. Primary insights were obtained through interviews with key industry thought leaders, supply chain specialists, and payer representatives. Quantitative findings were validated via data triangulation, peer review, and editorial quality control to ensure depth and reliability.
Why This Report Matters
- Delivers actionable segmentation and geographic granularity to guide portfolio scaling, commercialization, and strategic planning.
- Supports operational resilience by anticipating regulatory, tariff, and supply chain risks relevant to biologics management.
- Informs investment and partnership decisions by mapping innovation, digital integration, and competitor positioning across the market.
Conclusion
This report equips decision-makers with a strategic overview of liraglutide injection’s evolving landscape, synthesizing commercial, clinical, and regulatory insights. The clear framework provided supports timely actions and informed investments to sustain success in a dynamic therapeutic market.
Company Coverage
- Novo Nordisk A/S
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding off-label use in weight management and obesity treatment boosting demand
5.2. Emerging biosimilar competition offering cost-effective alternatives to branded liraglutide
5.3. Growing utilization of digital health platforms for real-time remote patient monitoring adherence
5.4. Advancements in clinical trials exploring cardiovascular outcomes with liraglutide therapy
5.5. Increasing integration of GLP-1 agonists in fixed-dose combination treatments for type 2 diabetes
5.6. Dynamic pricing and reimbursement strategies shaping liraglutide market access across global regions
5.7. Innovations in pen injectors and smart delivery devices enhancing patient convenience and adherence
5.2. Emerging biosimilar competition offering cost-effective alternatives to branded liraglutide
5.3. Growing utilization of digital health platforms for real-time remote patient monitoring adherence
5.4. Advancements in clinical trials exploring cardiovascular outcomes with liraglutide therapy
5.5. Increasing integration of GLP-1 agonists in fixed-dose combination treatments for type 2 diabetes
5.6. Dynamic pricing and reimbursement strategies shaping liraglutide market access across global regions
5.7. Innovations in pen injectors and smart delivery devices enhancing patient convenience and adherence
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Liraglutide Injection Market, by Indication
8.1. Introduction
8.2. Obesity
8.2.1. Class I
8.2.2. Class II
8.2.3. Class III
8.3. Type 2 Diabetes
8.3.1. Adults
8.3.2. Pediatrics
8.2. Obesity
8.2.1. Class I
8.2.2. Class II
8.2.3. Class III
8.3. Type 2 Diabetes
8.3.1. Adults
8.3.2. Pediatrics
9. Liraglutide Injection Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.2.1. Private
9.2.2. Public
9.3. Online Pharmacy
9.3.1. Manufacturer Portal
9.3.2. Third Party
9.4. Retail Pharmacy
9.4.1. Chain
9.4.2. Independent
9.2. Hospital Pharmacy
9.2.1. Private
9.2.2. Public
9.3. Online Pharmacy
9.3.1. Manufacturer Portal
9.3.2. Third Party
9.4. Retail Pharmacy
9.4.1. Chain
9.4.2. Independent
10. Liraglutide Injection Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. General
10.2.2. Specialty
10.3. Home Care
10.3.1. Nurse Administration
10.3.2. Self Administration
10.4. Hospitals
10.4.1. Private
10.4.2. Public
10.2. Clinics
10.2.1. General
10.2.2. Specialty
10.3. Home Care
10.3.1. Nurse Administration
10.3.2. Self Administration
10.4. Hospitals
10.4.1. Private
10.4.2. Public
11. Liraglutide Injection Market, by Dosage Strength
11.1. Introduction
11.2. 0.6 Mg
11.3. 1.2 Mg
11.4. 1.8 Mg
11.2. 0.6 Mg
11.3. 1.2 Mg
11.4. 1.8 Mg
12. Liraglutide Injection Market, by Packaging Type
12.1. Introduction
12.2. Pre Filled Pen
12.3. Single Dose Vial
12.2. Pre Filled Pen
12.3. Single Dose Vial
13. Americas Liraglutide Injection Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Liraglutide Injection Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Liraglutide Injection Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novo Nordisk A/S
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novo Nordisk A/S
List of Figures
FIGURE 1. LIRAGLUTIDE INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LIRAGLUTIDE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LIRAGLUTIDE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LIRAGLUTIDE INJECTION MARKET: RESEARCHAI
FIGURE 26. LIRAGLUTIDE INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 27. LIRAGLUTIDE INJECTION MARKET: RESEARCHCONTACTS
FIGURE 28. LIRAGLUTIDE INJECTION MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LIRAGLUTIDE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LIRAGLUTIDE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LIRAGLUTIDE INJECTION MARKET: RESEARCHAI
FIGURE 26. LIRAGLUTIDE INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 27. LIRAGLUTIDE INJECTION MARKET: RESEARCHCONTACTS
FIGURE 28. LIRAGLUTIDE INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIRAGLUTIDE INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS II, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS II, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS III, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS III, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY MANUFACTURER PORTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY MANUFACTURER PORTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY THIRD PARTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY GENERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SPECIALTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY NURSE ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY NURSE ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 0.6 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 0.6 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.2 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.2 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.8 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.8 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRE FILLED PEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRE FILLED PEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 154. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 155. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 156. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 157. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 162. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 163. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 170. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 171. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 174. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 175. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 200. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 201. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 309. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 312. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 313. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 314. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 315. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 326. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 327. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 328. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 329. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 330. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 331. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS II, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS II, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS III, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLASS III, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY MANUFACTURER PORTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY MANUFACTURER PORTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY THIRD PARTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY GENERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SPECIALTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY NURSE ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY NURSE ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 0.6 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 0.6 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.2 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.2 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.8 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY 1.8 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRE FILLED PEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY PRE FILLED PEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LIRAGLUTIDE INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES LIRAGLUTIDE INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 154. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 155. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 156. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 157. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 162. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 163. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 170. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 171. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 174. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 175. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 200. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 201. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA LIRAGLUTIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM LIRAGLUTIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 309. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2018-2024 (USD MILLION)
TABLE 312. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY OBESITY, 2025-2030 (USD MILLION)
TABLE 313. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2024 (USD MILLION)
TABLE 314. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY TYPE 2 DIABETES, 2025-2030 (USD MILLION)
TABLE 315. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 326. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 327. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 328. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 329. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 330. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 331. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. GERMANY LIRAGLUTIDE INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD
Samples
LOADING...
Companies Mentioned
The companies profiled in this Liraglutide Injection Market report include:- Novo Nordisk A/S
